MSH Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
MSH Capital Advisors's LLY Position: Q1 2026 in Review
MSH Capital Advisors increased its Eli Lilly (LLY) stake by 0.3% in Q1 2026, buying an estimated $4.05K and bringing the position to 1,339 shares worth $1.23M. The position accounts for 0.26% of the portfolio, ranked #100.
MSH Capital Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.49M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- MSH Capital Advisors held 1,339 shares of Eli Lilly worth $1.23M as of Q1 2026.
- MSH Capital Advisors bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
- Eli Lilly made up 0.26% of MSH Capital Advisors's portfolio in Q1 2026, its #100 holding.
- MSH Capital Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- MSH Capital Advisors's Eli Lilly position peaked at $1.49M in Q4 2023.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on MSH Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.